UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Journal of clinical oncology, 2006-09, Vol.24 (27), p.4472-4478

2006

Volltextzugriff (PDF)

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: Perception versus reality

Cancer, 2004-05, Vol.100 (10), p.2261-2268

2004

Volltextzugriff (PDF)

Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care

American journal of hematology, 2012-05, Vol.87 (5), p.558-561

2012

Volltextzugriff (PDF)

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

Annals of oncology, 2004-03, Vol.15 (3), p.526-536

2004

Volltextzugriff (PDF)

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life

Supportive care in cancer, 2007-02, Vol.15 (2), p.179-185

2007

Volltextzugriff (PDF)

Determining the cost of a bleeding-related episode in primary adult chronic immune thrombocytopenia (ITP) in the United States

Value in health, 2013-05, Vol.16 (3), p.A117-A117

2013

Volltextzugriff (PDF)

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis

Pediatrics (Evanston), 2002-10, Vol.110 (4), p.653-661

2002

Volltextzugriff (PDF)

The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation

American journal of public health (1971), 1999-11, Vol.89 (11), p.1722-1727

1999

Volltextzugriff (PDF)

Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue

Journal of medical economics, 2012, Vol.15 (2), p.313-331

2012

Volltextzugriff (PDF)

PO018 Measuring health-related quality of life impact of thrombocytopenia in MDS patients: results from a literature search

Leukemia research, 2007, Vol.31, p.S137-S138

2007

Volltextzugriff (PDF)

PSY36 - Determining the cost of a bleeding-related episode in primary adult chronic immune thrombocytopenia (ITP) in the United States

Value in health, 2013-05, Vol.16 (3), p.A117-A117

2013

Volltextzugriff (PDF)

P101 Thrombocytopenia in MDS: incidence and impact

Leukemia research, 2007, Vol.31, p.S94-S95

2007

Volltextzugriff (PDF)

Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics

Cancer, 2004-05, Vol.100 (10), p.2261-2668

2004

Volltextzugriff (PDF)

Chemotherapy-induced nausea and vomiting in routine practice: a European perspective

Supportive care in cancer, 2004-10, Vol.12 (10), p.708-715

2004

Volltextzugriff (PDF)

Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes

Supportive care in cancer, 2005-05, Vol.13 (5), p.277-286

2005

Volltextzugriff (PDF)

Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: Results of a survey of 985 patients

Clinical therapeutics, 2008-08, Vol.30 (8), p.1540-1552

2008

Volltextzugriff (PDF)

PSY48 IMPACT OF IMMUNETHROMBOCYTOPENIC PURPURA ON HEALTH CARE RESOURCE USE ANDWORKPLACE PRODUCTIVITY

Value in health, 2008, Vol.11 (3), p.A167-A167

2008

Volltextzugriff (PDF)

PSY38 ELICITING HEALTH STATE UTILITIES FOR IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA: RESULTS OF A GENERAL PUBLIC BASED TIME TRADE-OFF SURVEY

Value in health, 2009, Vol.12 (7), p.A382-A382

2009

Volltextzugriff (PDF)

PSY41 MEASUREMENT OF HEALTH UTILITY VALUES IN THE UK FOR HEALTH STATES RELATED TO IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA (ITP)

Value in health, 2009, Vol.12 (7), p.A383-A383

2009

Volltextzugriff (PDF)

Combien coûte la prise en charge d’un purpura thrombopénique immunologique chronique de l’adulte ? À propos d’une étude monocentrique de 57 cas

La revue de medecine interne, 2009-12, Vol.30, p.S333-S334

2009

Volltextzugriff (PDF)

Integrating livestock into farming systems in Northern Cameroon

Agricultural systems, 1992, Vol.38 (3), p.319-338

1992

Volltextzugriff (PDF)

Addressing the challenges to immunization practice with an economic algorithm for vaccine selection

Vaccine, 1998-11, Vol.16 (19), p.1885-1897

1998

Volltextzugriff (PDF)

Rotavirus Vaccine and Intussusception: How Much Risk Will Parents in the United States Accept to Obtain Vaccine Benefits?

American journal of epidemiology, 2001-12, Vol.154 (11), p.1077-1085

2001

Volltextzugriff (PDF)

Risk sharing versus low-cost credit systems for international development

American journal of agricultural economics, 1990-11, Vol.72 (4), p.911-922

1990

Volltextzugriff (PDF)

Measuring yield risk effects of new technologies with on-farm trials: A case study in north Cameroon

Agricultural systems, 1995, Vol.48 (2), p.223-240

1995

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(56)
Reviews
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(17)
Biological And Medical Sciences
(12)
Female
(12)
Male
(12)
Medical Sciences
(12)
Middle Aged
(9)
Quality Of Life
(8)
Adult
(7)
Chemotherapy
(7)
Nausea
(7)
Nausea - Chemically Induced
(6)
Oncology
(6)
Prospective Studies
(6)
Vomiting - Chemically Induced
(6)
Adolescent
(5)
Aged
(5)
Agriculture
(5)
Antineoplastic Agents - Adverse Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics: Perception versus reality

Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life

Determining the cost of a bleeding-related episode in primary adult chronic immune thrombocytopenia (ITP) in the United States

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis

The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation

Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue

PO018 Measuring health-related quality of life impact of thrombocytopenia in MDS patients: results from a literature search

PSY36 - Determining the cost of a bleeding-related episode in primary adult chronic immune thrombocytopenia (ITP) in the United States

P101 Thrombocytopenia in MDS: incidence and impact

Incidence of chemotherapy‐induced nausea and emesis after modern antiemetics

Chemotherapy-induced nausea and vomiting in routine practice: a European perspective

Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes

Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: Results of a survey of 985 patients

PSY48 IMPACT OF IMMUNETHROMBOCYTOPENIC PURPURA ON HEALTH CARE RESOURCE USE ANDWORKPLACE PRODUCTIVITY

PSY38 ELICITING HEALTH STATE UTILITIES FOR IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA: RESULTS OF A GENERAL PUBLIC BASED TIME TRADE-OFF SURVEY

PSY41 MEASUREMENT OF HEALTH UTILITY VALUES IN THE UK FOR HEALTH STATES RELATED TO IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA (ITP)

Combien coûte la prise en charge d’un purpura thrombopénique immunologique chronique de l’adulte ? À propos d’une étude monocentrique de 57 cas

Integrating livestock into farming systems in Northern Cameroon

Addressing the challenges to immunization practice with an economic algorithm for vaccine selection

Rotavirus Vaccine and Intussusception: How Much Risk Will Parents in the United States Accept to Obtain Vaccine Benefits?

Risk sharing versus low-cost credit systems for international development

Measuring yield risk effects of new technologies with on-farm trials: A case study in north Cameroon

Suchergebnisse filtern